Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8

Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 6 2 2020
medline: 6 2 2020
entrez: 5 2 2020
Statut: ppublish

Résumé

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41586-020-2002-9 PMID: 32015546
pubmed: 32015546
doi: 10.1038/s41586-020-2002-9
pii: 10.1038/s41586-020-2002-9
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

E21

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI090797
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI126619
Pays : United States

Commentaires et corrections

Type : ErratumFor

Auteurs

Julia Bergild McBrien (JB)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Maud Mavigner (M)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.

Lavinia Franchitti (L)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

S Abigail Smith (SA)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Erick White (E)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Gregory K Tharp (GK)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Hasse Walum (H)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Kathleen Busman-Sahay (K)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.

Christian R Aguilera-Sandoval (CR)

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

William O Thayer (WO)

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Rae Ann Spagnuolo (RA)

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Martina Kovarova (M)

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Angela Wahl (A)

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Barbara Cervasi (B)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

David M Margolis (DM)

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
University of North Carolina HIV Cure Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Thomas H Vanderford (TH)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Diane G Carnathan (DG)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Mirko Paiardini (M)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Jeffrey D Lifson (JD)

AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

John H Lee (JH)

NantKwest, Culver City, CA, USA.

Jeffrey T Safrit (JT)

NantKwest, Culver City, CA, USA.

Steven E Bosinger (SE)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Jacob D Estes (JD)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.

Cynthia A Derdeyn (CA)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.

J Victor Garcia (JV)

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Deanna A Kulpa (DA)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Ann Chahroudi (A)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Emory + Children's Center for Childhood Infections and Vaccines, Atlanta, GA, USA.

Guido Silvestri (G)

Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA. gsilves@emory.edu.
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. gsilves@emory.edu.

Classifications MeSH